Literature DB >> 32191432

Chemical Modulation of Pre-mRNA Splicing in Mammalian Systems.

Robert E Boer1, Zachary R Torrey1, John S Schneekloth1.   

Abstract

RNA splicing is a key component of gene expression and proteomic diversity in humans. The spliceosome assembles on and processes individual nascent pre-mRNA transcripts into distinct mature mRNAs that can code for different proteins. Splicing programs can be affected by somatic mutations and changes in response to exogenous stimuli. Importantly, alterations in splicing can be direct drivers of diseases including cancers. This Review describes recent advances and the potential for targeting and controlling pre-mRNA splicing in humans with small molecules, ranging from targeting spliceosomal proteins to direct targeting of individual RNA transcripts.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32191432     DOI: 10.1021/acschembio.0c00001

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  8 in total

1.  RNA: Opening New Doors in Medicinal Chemistry.

Authors:  Amanda L Garner; Stevan W Djuric
Journal:  ACS Med Chem Lett       Date:  2020-08-19       Impact factor: 4.345

2.  Novel Heteroaryl Compounds as Splicing Modulators for Modulating Splicing of mRNA and Uses Thereof for Treating Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-05-05       Impact factor: 4.632

3.  Novel Substituted Thiadiazoles as Splicing Modulators for Modulating Splicing of mRNA and Uses Thereof for Treating Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-05-06       Impact factor: 4.632

4.  Novel Substituted Pyridazines as Splicing Modulators for Modulating Splicing of mRNA and Uses Thereof for Treating Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-04-29       Impact factor: 4.632

5.  Novel Substituted Triazines as Splicing Modulators for Modulating Splicing of mRNA and Uses Thereof for Treating Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-04-30       Impact factor: 4.632

6.  Novel Substituted Pyrazines as Splicing Modulators for Modulating Splicing of mRNA and Uses Thereof for Treating Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-05-05       Impact factor: 4.632

7.  Novel Substituted Pyridazines as Splicing Modulators for Modulating Splicing of mRNA and Uses Thereof for Treating Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-04-30       Impact factor: 4.632

Review 8.  Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations.

Authors:  Craig S McIntosh; Gerald F Watts; Steve D Wilton; May T Aung-Htut
Journal:  Curr Opin Lipidol       Date:  2021-12-01       Impact factor: 4.776

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.